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1. Introduction
Androgenetic alopecia is the common type of hair loss in men and women since puberty.
Typically, AA is the complex result of an androgen-dependent process and this process is
located to androgen receptor (AR) areas (frontal and vertex zone). Number of androgen
receptors is genetic transmission. The polymorphism involving the CAG triple repeat expan‐
sion of the AR protein has been revealed in men with AA. This male pattern hair loss may
represents from influence of minimal androgen excess basing on genetically sensitive hair
papilla.
Dihydrotestosterone (DHT) is derived from circulating testosterone (T) inhibits cell prolifer‐
ation in the dermal papilla and local production of vascular endothelial growth factor [1]. As
a result, the DHT-dependent process leads to the miniaturization of sensitive hair follicles and
progressive thinning the scalp hair. It is known that the follicular dermal papilla controls hair
growth. Steroid hormones, including androgens, estrogens and glucocorticoids may influence
on timing of hair cycle [2].
More recent studies have focused on androgen-regulated hair growth. But, studies of action
of other steroids in the hair follicle have been relatively limited. There are two estrogen
receptors (ERα and ERβ) which bind to 17β-estradiol. The effects of estrogens seem complex
whereby estrogen prolongs the anagen phase of the hair follicle and stimulates hair shaft
elongation [2]. ERβ expression was found in outer root shaft and epithelial matrix. In contrast,
ERα and AR were expressed in dermal papilla [3].Therefore, the ratio of ERα to ERβ in dermal
papilla cells is extremely important. Estrogen also modifies androgen metabolism. The local
production of estrogens from androgen precursors has been converted by the aromatase
cytochrome P 450 enzyme complex. It is now clear there is aromatase expression in the dermal
papilla and the outer root sheath. The activity of aromatase is higher in women in occipital
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scalp area compared to the frontal scalp and it has been diminished in AA [4]. Some researchers
found that estradiol inhibited 5 alpha-reductase activities [5]. The effects on estrogens might
be explained by an increased conversion of T to the weaker androgens such as androstendione
and androstendiol. Progesterone is able to modulate activity of DHT in dermal papilla by 75%
[4, 6]. Also, progesterone is widely recognized as a marker of estrogen action and has anti-
inflammatory properties. Progesterone regulates the expression of matrix metalloproteinases
(MMPs) by transforming growth factor-β [7].
However, in women hair loss is not limited to only this location and combined with diffuse
alopecia. Except in some cases, treatment of 5 alpha reductase inhibitors is ineffective in
women. The origin and mechanisms of AA in women are different and more complicated than
in men and remain a challenge.
The aim of the work was to estimate a possible role of trace elements (TE) changes in AA in
man and women.
2. Materials and methods
In this study, 97 women and 40 men, ages 20-55 y., with AA were selected for the determination
of TE content and CP in serum, hormonal status. Diagnosis of AA was based on clinical
findings, pattern of increased hair thinning on frontal/vertex scalp with greater hair density
on occipital scalp zone; retention of frontal hairline; and the presence of miniaturized hairs
(vellus hair, diameter less 30 μkm). Detailed study of the consumption of drugs, iron intake
and thyroid metabolism ruled out other types of alopecia. The degree of AA was determined
Figure 1. The hair shaft
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by application of Ludwig scales (II–III). Exclusion criteria were: replacement hormone therapy
(RHT) with estrogens, progesterone, testosterone, L-thyroxin or corticoids during last 6
months. Women’s group was divided by 5 subgroups: women with excess of androgens, ages
before 40 and after 40 y.o. (22 and 19 correspondently), women with excess of estrogens before
and after 40 y.o. (24 and 17) and women with obesity at age of 20-40 year (16 patients). Women
had both AA and the other sings of elevated androgens level (hirsutism and acne) were
included in group with excess of androgens (HA 1 and 2). Women in group with excess of
estrogens had endometriosis, uterine leiomyoma or combining both of these (HE 1 and 2).
Childbearing aged women with abdominal obesity (waist >88 cm.) and excess of ALT con‐
centration in blood were enrolled in group with obesity (O1). Control group included in age-
matched men and women (76 and 32 patients correspondently) who presented no diseases at
the time of examine. The concentration of TE has been analyzed by ICP mass-spectrometer
Nexion-300D and Elan-9000 (Perkin Elmer Corp., USA). Reference materials of serum and hair
samples were used. The level of FSH (follicle-stimulated hormone), LT (leuteotpophic), 17β-
estradiol (E2), progesterone (PR), prolactin, androstendione (A), dihydrotestosterone (DHT)
and sex hormone bound globulin (SHPG) was tested by routine laboratory methods.
Statistical analyses were performed with the ANOVA software (Statistics version 7). We
applied non parametrical statistics: median, 25 and 75 percentiles. Student’s t-test was used to
Figure 2. The timing of the hair cycle
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compare the values of quantitative variables. Correlations among variables were studied using
the Pearson’s coefficient. P ≤ 0.05 was considered significant in all analyses.
3. Results
No significant differences of TE serum content in men and women were found between AA
patients and control group. The exception was the concentration of copper (Cu) which was
statistically significant differences between men and women suffering from AA and matched
control (Table 1). In present work in women with hyperandrogenism there are the some trends
in TE content in serum than in men. The key disorder was decreased Cu level in frontal zones
of scalp hair and serum.
Ele
me
nt
Men Women
AA group, n=40 Control, n=32 AA group, n=97 Control, n=76
Me
dia
n Persencile
(25-75) Me
dia
n Persencile
(25-75) Me
dia
n Persencile
(25-75) Me
dia
n Persencile
(25-75)
As 0,019 0,015-0,025 0,015 0,008-0,028 0,018 0,007-0,028 0,02 0,01-0,032
Ca 92,3 88,2- 98,5 96,1 91,0-101,0 95,8 90,6-102,4 95,3 89,6-103,3
Co 0,0005 0,0004-0,0006 0,0006 0,0004-0,0007 0,006 0,0005-0,0008 0,0006 0,0005-0,0008
Cu 0,80 0,70-0,85 0,88* 0,75-1,06 0,85 0,77-0,94 0,99* 0,90-1,11
Fe 1,3 1,0-1,5 1,4 1,3-1,5 1,3 1,0-1,6 1,2 0,78-1,46
K 183 169-196 187 178-199 170 158-193 178 157-204
Mg 20,7 19,9-21,2 20,7 19,3-22,4 20,3 19,1-21,5 20,8 19,4-22,4
Mn 0,0034 0,0030-0,0038 0,0037 0,0031-0,0048 0,0032 0,0027-0,0039 0,0032 0,0026-0,0043
Mo 0,0008 0,0007-0,0012 0,0009 0,0007-0,0012 0,0009 0,0007-0,0012 0,001 0,0008-0,0014
Ni 0,006 0,005-0,007 0,006 0,005-0,008 0,006 0,005-0,007 0,006 0,005-0,008
Se 0,14 0,13-0,16 0,16 0,13-0,17 0,14 0,13-0,17 0,14 0,13-0,16
Zn 0,89 0,83-1,04 0,91 0,82-1,10 0,81 0,72-0,95 0,83 0,69-1,06
*-P<0, 01 (differences between control group and AA’s group)
Table 1. Trace elements content (mkg/ml) in serum in men and women with AA
In spite of sex decreased Cu concentration in serum were obtained in patients with AA.
However, Cu level in women was higher in comparison to men.
Median, 25-th and 75-th percentiles values in women with AA and accompanying other
diseases are summarized in Table 2.
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Element HA1n=22
HA2
n=19
O1
n=24
HE1
n=17
HE2
n=16
Control
n=76
As 0,017(0,007-0,031)
0,020
(0,008-0,031)
0,016
(0,006-0,038)
0,014
(0,006-0,023)
0,012
(0,007-0,031)
0,020
(0,010-0,032)
Ca 95,8(91,5-98,0)
101,1
(89,3-104,0)
91,3
(87,2-97,5)
97,8
(87,1-100,5)
93,5
(91,7-97,1)
95,3
(89,6-103,3)
Co 0,0006(0,0005-0,0007)
0,0005
(0,0004-0,0007)
0,0006
(0,0004-0,0008)
0,0007
(0,0005-0,0008)
0,0007
(0,0005-0,0010)
0,0006
(0,0005-0,0008)
Cu 0,81*(0,72-0,89)
0,85*
(0,80-0,91)
0,94
(0,81-1,08)
0,97**
(0,86-1,19)
0,99**
(0,89-1,21)
0,99
(0,90-1,11)
Fe 1,3(1,1-1,7)
1,2
(1,1-1,4)
1,2
(0,8-1,6)
1,3
(0,4-1,5)
1,1
(0,6-1,4)
1,2
(0,8-1,5)
K 183(164-204)
193
(169-291)
183
(165-194)
195
(175-234)
170
(153-190)
178
(157-204)
Mg 20,4(19,1-21,8)
20,9
(20,1-22,1)
19,6
(18,4-21,4)
20,5
(18,7-22,3)
19,6
(18,1-20,5)
20,8
(19,4-22,4)
Mn 0,0033(0,0027-0,0040)
0,0035
(0,0030-0,0039)
0,0031
(0,0026-0,0034)
0,0030
(0,0027-0,0035)
0,0033
(0,0027-0,0036)
0,0032
(0,0026-0,0043)
Mo 0,0009(0,0007-0,0013)
0,0007
(0,0005-0,0010)
0,0009
(0,0006-0,0011)
0,0008
(0,0006-0,0009)
0,0007
(0,0007-0,0008)
0,0010
(0,0008-0,0014)
Ni 0,006(0,005-0,007)
0,006
(0,005-0,007)
0,006
(0,004-0,007)
0,005
(0,005-0,006)
0,005
(0,004-0,006)
0,006
(0,005-0,008)
Se 0,15(0,13-0,16)
0,14
(0,14-0,16)
0,15
(0,13-0,16)
0,14
(0,12-0,16)
0,14
(0,13-0,15)
0,14
(0,13-0,16)
Zn 0,93(0,82-1,05)
0,85
(0,75-1,07)
0,70*
(0,66-0,76)
0,89
(0,80-0,95)
0,79
(0,69-1,19)
0,83
(0,69-1,06)
Cu/Mn 239(187-306)
245
(213-277)
319
(278-369)
336**
(300-438)
349**
(282-420)
288
(253-370)
Cu/Zn 0,82*(0,73-1,06)
1,01
(0,76-1,14)
1,31*
(1,22-1,40)
1,12
(1,04-1,25)
1,12
(0,82-1,50)
1,22
(0,94-1,42)
*-P<0,005 (differences between control group and others)
**-P<0, 05 (differences between groups with excess of androgens (HA1) and estrogens (HE 1 or 2)).
Table 2. TE content and ratio Cu/Mn and Cu/Zn (Median, 25-75th percentiles) in women with AA and associated with
different diseases.
When we separated women with AA into subgroups there have obtained differences between
control and investigated groups. No significant differences were found between AA patients
and control in the majority of TE content in serum. Although the lowest Cu content was
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observed in group combining AA with other sing of excess of androgens such as hirsutism
and acne.
Figure 3. Content of Cu, Zn and ceruloplasmin (CP) in men and women with AA
Cu concentration in groups with elevated androgens level and with appearance of several
marks of androgens abundance was lower than in the whole women group with AA. There
were statistically significant differences between Cu level in groups with plenty of androgens
and estrogen. In case of being endometriosis or uterine leiomyoma (HE1 and 2) in women Cu
concentration in serum have maintained the same than in control, although not decreased in
patients with AA. The overflowed androgens in women were conducted the reduction Cu
content in serum considerably. The zinc (Zn) level was the lowest in women who combined
AA and abdominal obesity. There was variety Zn content in serum in women at ages. In women
under 40 year of age either elevated androgens or excess of estrogen the Zn level was getting
low as compared to women before 40 year. The ratio Cu/Mn in women HE1 and 2 groups has
been elevated significantly in comparison with groups with excess of androgens.
There was a tendency to raise the ratio Cu/Mn in women with elevated estrogen level as
compared to control. The ratio Cu/Zn was significant lower in women any ages with abundant
of androgens than in control. But, in case of abdominal obesity the values of this ratio were
higher in comparison with control group.
4. Discussion
The hair follicle represents a unique, highly regenerative neuroectodermal – mesodermal
interaction system. These transformations are controlled by changes in the expression/ activity
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of a numerous growing factors, cytokines, hormones, neurotransmitters, as well as transcrip‐
tion factors and enzymes.
Alopecia areata (AA) is the most common type of alopecia that the onset after puberty in both
sexes. AA may affect up to 70 of men and 40% of women [8]. Male and female pattern hair loss
are clinically distinct entities but pathogenically indistinguishable. The main role in the onset
of AA in men is local disturbances in androgens metabolism which based on genetic predis‐
poses to converse of terminal hair in vellus-like hair. AA is a polygenetic hereditary disease.
A low number of CAG repeats in the androgen receptor gene implies increased risk factor for
AA; prostate hyperplasia, coronary heart disease. But the role of sex hormones in females is
less understood. Same of women suffering from AA are revealed androgens excess with other
signs of elevated androgens such as hirsutism, acne, polycystic ovary syndrome. In women
there is the appearance of AA combining with diffuse hair loss [9].
AA in men is due to implicate DNT production by 5 alpha-reductase type 2. The primary
precursor of DHT in men is testosterone. The androgen receptor (AR) binding leads to increase
production of cytokines such as TGFβ-1 and 2, which promote telogen, thinning and shorten‐
ing hair. There is a low number of AR in occipital hair follicles that hair loss is mostly restricted
to the scalp vertex and frontal and temporal areas. The using of a type 2 – selective inhibitor
demonstrated the improvements in scalp hair growth in men. On stopping finasteride
treatment, the balding process resumed. However, finasteride has been associated with
depressive symptoms, persistent sexual side effects (loss of libido and erectile function). In
contract to its beneficial effects of finasteride (5 alpha–reductase’s inhibitor) in men; it didn’t
Figure 4. Cu content and ratio Cu/Mn in women with AA
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improve hair growth in women with AA. These findings suggested that the molecular
mechanisms involved in the different metabolic ways in regulations hair growth in women.
Women with some markers of insulin resistant have increased risk of AA [9]. Several studies
have analyzed the relationship between androgenetic alopecia and cardiovascular disease.
Women with AGA showed higher significant mean values than non-alopecic women for all
the parameters (triglyceridaemia, LDL-C, total cholesterol, total cholesterol/HDL-C and LDL-
C/HDL-C) and lower significant HDL-C than controls.
Estrogens are indirect anti-androgens which increase SHMG production by binding to
androgens and reducing their bioavailability. The production of estrogens from androgens via
aromatase is of the importance in hair follicles. The comparison of scalp biopsies from men
and women with AA revealed aromatase levels to be higher in hair follicles from occipital area
in comparison to the frontal hair follicles. Furthermore, aromatase levels has found in six times
higher in women when compared to men. Recent study has demonstrated that both dermal
papilla and outer root sheath expressed aromatase activity. The levels of ER expression and
aromatase activity may be modulated by steroid hormones in other tissues it would be
important in the hair follicle. Likewise androgens have been reported to alter the ration of
ERα to ERβ [2]. The alteration in the ratio of ERα to ERβ in dermal papilla cells could promote
E2 signaling via ERβ in preference to ERα.
Since the hair follicles has been shown to express AR, glucocorticoid receptor, ERα, ERβ and
progesterone receptors (PRα and PRβ). Both the dermal papilla cells and surrounding
epithelial cells express ER. Additional local productions of E2 via conversion from A by
aromatase may act in either an autocrine or paracrine manner to control lair growth and
differentiation. In experimental studies PR inhibited the synthesis of DHT in dermal papilla
by 75%. E2 was less able inhibit its production [6].
However, no direct effects of prolactin on hair growth have been reported [11]. Progesterone
acts via PR receptors on cells to induce secretion of paracrine factor that in turn stimulate the
expression 17β –hydroxysteroid dehydrogenase type 2 (HSD17β2). HSD17β2 metabolizes E2
to weak estrogenic estrone. The control of hair growth by E2 is much more complex than
previously appreciated.
The E2 may modulate hair growth by interfering with androgen metabolism [12]. The
estrogenic effects on dermal papilla cells are mediated via ERα.The role of ERβ may be to
protect tissues from oxidative stress by inducing battery of antioxidative enzymes. Under
hyperestrogenic conditions, the ratio PRβ to PRα is decreased but ratio ERβ to ERα is elevated
in endometriosis and uterine leiomyoma. Serum Cu level is known to control by estrogens.
Under excess of androgens Cu content in serum was decreased and associated with elevated
DHT level which results of 5alpha-reductase type 2 activities. The pathogenic mechanism of
AA is case of abundant of androgens doesn’t differ in men and women with high androgens
level. The development of AA shows up other clinical marks of androgens excess (hirsutism
and acne) and reflect the interaction androgens and estrogen metabolism. Both AR and ERα
are located into dermal papilla and influenced on hair growth [4]. In some studies have shown
there was depressed ratio E2 to androgens [13].
Pharmacology and Nutritional Intervention in the Treatment of Disease344
We demonstrated the development of AA in women with endometriosis or /and uterine
leiomyoma. These diseases have usually revealed of estrogens excess, high activity of aroma‐
tase and decreased level of progesterone. There was a high level of ratio ERβ to ERα against
the background of changed ratio progesterone receptor (PRα/PRβ). The onset and develop‐
ment of AA in this group didn’t link to abundant androgens level.
Figure 5. Proposed schema of TE dependent androgenetic alopecia
Normal or excess estrogens concentration and deficiency or resistant to progesterone were
typical in these women. Cu content in serum and ratio Cu/Mn determined higher than in
control. But, Mn level in these groups remains lower to compare with control. These data
suggest that the important value in appearance of AA belongs to the relationship between E2
and PR and ratio of their receptors in peripheral tissues. About 15% from all examined women
with AA have been detected the cut-off Mn level. Mn is known to impede the female and male
reproductive function. In experimental studies the relationship Mn concentration and
progesterone level have been shown. There is the high level of Mn-COD in lutein phase of
menstrual cycle [14]. Manganese superoxide dismutase (Mn–COD), an antioxidant enzyme in
the mitochondria, protects cells by scavenging superoxide radicals. Mn–COD increases by
inducing progesterone. Experimental data suggests that Mn down-regulated steroidogenesis
in Leydig cells [15]. Mn influences the receptor signaling pathways and contractile machinery
of vascular smooth muscle cells [16]. The expression of Mn-COD was significantly increased
by 17β–estrogen and testosterone in neutrophil granulocytes in healthy volunteers [17]. In our
work we hypothesize that the assignment of low Mn content may reflect depressed value of
PR, changed ratio PR receptors or cell’s resistance to PR.
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In women serum ferritin levels may also be assessed to determine hair loss. Appreciating the
importance of iron as a factor in hair loss may be important in the therapy in a variety of
etiologically distinct forms of hair loss. According to obtained findings there was no statistical
difference in iron content between control and experimental groups [18].
Condition excess of A excess of estrogen
Hormonal status ↑ A→DHT ↑E, ↓Progesterone, ± A
Receptors AR→ alteration ratio ERα/ERß alteration ratio ERα/ERß and PRβ/PRα
Age after puberty middle age and premenopausal
Treatment decrease level of A and modulation ofratio ER’s
increase level of progesterone and
modulation of ratio ER’s
Table 3. The difference of the onset and development of AA under excess of androgen or estrogen.
In this hypothetic scenario, there were two groups’ women with AA. One of them has been
registered excess of A in serum (Table 3). The other demonstrated normal level of A but had
the alteration of estrogen and progesterone contents in blood. A lot of hormones, growth’s
factors take part in development of AA. Many diseases have followed by AA. Typically, the
excess of A in blood in both men and women with AA have been revealed. Surprisingly, in
women with hyperestrogenic condition the onset of AA have shown. The comparable with
control level of A has been demonstrated in this group. Therefore, the ratio of ERα to ERß in
follicular dermal papilla cells may be important. The alteration of estrogen, progesterone and
androgen receptors has the key of metabolic disturbances in dermal papilla cells and outer
root sheath. That is why the typical approaches for treatment of AA which include in using
hormonal replacement therapy, inhibitors of DHT production and others were not fruitful.
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